Por favor, use este identificador para citar o enlazar este ítem:
http://ipicyt.repositorioinstitucional.mx/jspui/handle/1010/1485
Novel fusion protein derived from vasostatin 30 and vasoinhibin II-14.1 potently inhibits coronary endothelial cell proliferation | |
GABRIELA VAZQUEZ RODRIGUEZ María del Carmen González Castillo Antonio de León Rodríguez | |
Acceso Abierto | |
Atribución-NoComercial-SinDerivadas | |
https://doi.org/10.1007/s12033-012-9642-4 | |
Angiogenesis Endothelium Cell proliferation Fusion protein Recombinant protein | |
"Angiogenesis has been considered an important target for cancer therapy. The inhibition of angiogenesis represents a promising strategy for anti-cancer treatment, tumor growth inhibition, and metastasis. Vasostatin 30 (Vs30), and the 14.1 kDa vasoinhibin (Vi-II-14.1) are two peptides with remarkable anti-tumor and anti-angiogenic effect. The aim of this study was to produce a novel fusion protein between Vs30 and Vi-II-14.1, denominated VS_VI, to obtain a new protein with higher biological activity. The protein fusion genes were cloned into a T7 promoter-based vector, expressed in Escherichia coli BL21-SI and purified by affinity column chromatography. In vitro assays showed that the recombinant fusion protein inhibited rat coronary endothelial cell proliferation at 65.5 % at 10 nM, whereas recombinant Vs30 and Vi-II-14.1 inhibited at 33 and 50.5 % respectively, at the same concentration. The results showed that VS_VI is significantly more active than the Vs30 and Vi-II-14.1 separately. In addition, a practical classification of the vasoinhibins based on the peptide origin and theoretical molecular weight is proposed. This is the first study to produce a new fusion protein derived from Vs30 and Vi-II-14.1, both of them proposed as promising therapeutic agents." | |
Humana Press Inc | |
2013-07 | |
Artículo | |
Vazquez Rodriguez, G., Gonzalez, C. & De Leon Rodriguez, A. Mol Biotechnol (2013) 54: 920. https://doi.org/10.1007/s12033-012-9642-4 | |
BIOLOGÍA MOLECULAR | |
Versión revisada | |
submittedVersion - Versión revisada | |
Aparece en las colecciones: | Publicaciones Científicas Biología Molecular |
Cargar archivos:
Fichero | Tamaño | Formato | |
---|---|---|---|
MolBiotechnol54(2013)920.pdf | 208.13 kB | Adobe PDF | Visualizar/Abrir |